Estimated Effectiveness and Cost-Effectiveness of Opioid Use Disorder Treatment Under Proposed U.S. Regulatory Relaxations: A Model-Based Analysis
This study finds that extending flexibilities for medication for opioid use disorder enacted during the COVID-19 pandemic is associated with health and cost benefits.
Peer-Reviewed Article